Harvest Fund Management Co. Ltd Increases Stock Holdings in HCA Healthcare, Inc. $HCA

Harvest Fund Management Co. Ltd grew its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 92.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,990 shares of the company’s stock after buying an additional 1,435 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in HCA Healthcare were worth $1,395,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Norges Bank purchased a new stake in HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $374,037,000. Viking Global Investors LP lifted its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after acquiring an additional 649,058 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $115,530,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Stock Performance

Shares of HCA stock opened at $372.29 on Friday. The company has a market capitalization of $82.59 billion, a price-to-earnings ratio of 12.80, a PEG ratio of 1.15 and a beta of 1.12. The stock’s 50 day simple moving average is $439.51 and its 200 day simple moving average is $477.20. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the business earned $6.45 EPS. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

Analysts Set New Price Targets

A number of research analysts recently commented on HCA shares. TD Cowen lowered their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Sanford C. Bernstein cut their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a report on Thursday. JPMorgan Chase & Co. reduced their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Finally, Robert W. Baird reduced their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $506.14.

Get Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.